Scarica l'app Stockscreener
95.45
1.09%
-1.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$96.50
Aprire:
$96.68
Volume 24 ore:
6.58M
Relative Volume:
0.94
Capitalizzazione di mercato:
$122.43B
Reddito:
$34.20B
Utile/perdita netta:
$4.69B
Rapporto P/E:
26.35
EPS:
3.6218
Flusso di cassa netto:
$5.30B
1 W Prestazione:
-2.30%
1M Prestazione:
+3.39%
6M Prestazione:
+15.64%
1 anno Prestazione:
+7.43%
Intervallo 1D:
$95.30
$97.05
Intervallo di 1 settimana:
$95.30
$99.37
Portata 52W:
$79.29
$99.37
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Confronta MDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Intuitive’s challengers continue to advance - MedTech Dive
RBC Raises Price Target on Medtronic to $111 From $103, Keeps Outperform Rating - MarketScreener
Medtronic (NYSE:MDT) Receives "Buy (B-)" Rating from Weiss Ratings - MarketBeat
US Bancorp DE Sells 97,898 Shares of Medtronic PLC $MDT - MarketBeat
Insight Inv LLC Cuts Stock Position in Medtronic PLC $MDT - MarketBeat
Columbus Macro LLC Purchases 13,416 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Leo Wealth LLC - MarketBeat
Medtronic PLC $MDT Holdings Decreased by Tectonic Advisors LLC - MarketBeat
Prime Capital Investment Advisors LLC Has $933,000 Stock Holdings in Medtronic PLC $MDT - MarketBeat
Multi factor analysis applied to Medtronic plcTrade Volume Report & Reliable Intraday Trade Alerts - newser.com
How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
What analysts say about Medtronic plc 2M6 stockBreakout Stock Watch & Low Entry Cost Investments - earlytimes.in
Stifel Maintains Medtronic (MDT) Hold Recommendation - Nasdaq
Medtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know - Nasdaq
Transcript : Medtronic plcSpecial Call - MarketScreener
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions - The Malaysian Reserve
Stifel Raises Medtronic (MDT) Price Target to $105, Maintains Ho - GuruFocus
Medtronic begins study of Hugo robot in gynecology - MedTech Dive
November 28th Options Now Available For Medtronic (MDT) - Nasdaq
Medtronic BrainSense Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions - Med-Tech Insights
Medtronic begins Embrace Gynecology study of Hugo RAS system - Medical Device Network
Stifel Adjusts Price Target on Medtronic to $105 From $90, Maintains Neutral Rating - MarketScreener
Advanced analytics toolkit walkthrough for Medtronic plcQuarterly Market Summary & Advanced Swing Trade Entry Alerts - newser.com
Stifel raises Medtronic stock price target to $105 on HUGO robotic progress - Investing.com UK
Optas LLC Boosts Position in Medtronic PLC $MDT - MarketBeat
Medtronic initiates FDA IDE study for Hugo surgical robot in gynecology - MassDevice
3rd Time's The Charm? The Tax Court's Odyssey In Medtronic - Law360
Medtronic Plc Hits New 52-Week High at USD 99.37 - Markets Mojo
Medtronic Delivers on FY25 Sustainability Targets and Charts Path to 2030 - ACCESS Newswire
What's Going On With Medtronic Stock Wednesday?Medtronic (NYSE:MDT) - Benzinga
Medtronic : delivers on FY25 sustainability targets and charts path to 2030 - MarketScreener
Medtronic (MDT) Launches Clinical Study for Robotic Surgery Syst - GuruFocus
Medtronic Initiates Clinical Study for Robotic-Assisted Surgery System for Gynecological Procedures - MarketScreener
Medtronic begins U.S. clinical study of Hugo robot for gynecological surgery - Investing.com India
Medtronic PLC $MDT Position Cut by Citizens National Bank Trust Department - MarketBeat
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures - Medtronic News
Medtronic PLC $MDT Shares Sold by Somerville Kurt F - MarketBeat
WestEnd Advisors LLC Increases Position in Medtronic PLC $MDT - MarketBeat
Medtronic launches VitalFlow ECMO in Europe - MassDevice
Medtronic (MDT) Receives Buy Rating and Increased Price Target f - GuruFocus
Medtronic launches full U.S. distribution of Neuroguard IEP carotid stent system - MassDevice
Global Insulin Delivery Devices Market is Predicted to Reach ~USD 53 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Medtronic : 2025 Impact Report - MarketScreener
Medtronic : Read more (2025 impact report corpmark mdt) - MarketScreener
Medtronic : launches full distribution of the Neuroguard IEP™ System, establishing a new era in treating patients with carotid artery disease - MarketScreener
Citigroup Adjusts Price Target on Medtronic to $112 From $101, Maintains Buy Rating - MarketScreener
Country Club Bank Decreases Stock Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic : Cardiac Surgery launches VitalFlow™ Extracorporeal Membrane Oxygenation (ECMO) system in Europe, advancing care for critically ill patients - MarketScreener
Godsey & Gibb Inc. Grows Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by KLP Kapitalforvaltning AS - MarketBeat
Seamount Financial Group Inc. Makes New Investment in Medtronic PLC $MDT - MarketBeat
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):